• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症儿科患者的临床特征及治疗方式评估:单中心经验

Evaluation of clinical features and treatment modality of pediatric patients with Steven Johnson syndrome/toxic epidermal necrolysis: a single-center experience.

作者信息

Güvenir Funda Aytekin, Çayhan Vildan Selin, Balci Selman Kürşat, Dere Ragıp, Çelik Hatice Irmak, Emeksiz Serhat, Selmanoğlu Ahmet, Emeksiz Zeynep Şengül, Şenel Emrah, Misirlioğlu Emine Dibek

机构信息

Division of Pediatric Allergy and Immunology, Department of Pediatrics, Ankara Bilkent City Hospital, Ankara, Turkiye.

Department of Pediatric Surgery, Ankara Bilkent City Hospital, Ankara, Turkiye.

出版信息

Turk J Med Sci. 2025 Feb 5;55(2):461-469. doi: 10.55730/1300-0144.5990. eCollection 2025.

DOI:10.55730/1300-0144.5990
PMID:40342328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12058029/
Abstract

BACKGROUND/AIM: Steven Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but life-threatening severe cutaneous drug hypersensitivity reactions. The aim of our study was to evaluate the clinical features of pediatric patients diagnosed with SJS, TEN or SJS/TEN overlap and to examine treatment modalities.

MATERIALS AND METHODS

Patients aged 0-18 years who were followed up with SJS, TEN or SJS/TEN overlap at Ankara Bilkent City Hospital between August 2019 and January 2024 were retrospectively analyzed.

RESULTS

Twelve patients who met the inclusion criteria were included in the study. Five of the patients had SJS, four had SJS/TEN overlap, and three had TEN. Eight of the patients were female, and the median age at presentation was 10.5 (IQR:6-16) years. Ten of the patients had a history of drug use. Eight patients had antibiotics, two had proton pump inhibitors, two had allopurinol, and two had antiepileptic (lamotrigine and valproic acid) use. All 12 patients received IVIG and systemic steroid therapy. Three TEN and four SJS/TEN overlap patients received cyclosporine. Two TEN patients underwent plasmapheresis. The most common long-term sequelae were dermatological sequelae.

CONCLUSION

SJS/TEN patients should be monitored with a multidisciplinary approach, and if necessary, in the burn intensive care unit. Primary treatment is supportive care. Early initiation of cyclosporine may have a positive effect on the prognosis in patients with SJS/TEN overlap and TEN.

摘要

背景/目的:史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)是罕见但危及生命的严重皮肤药物过敏反应。我们研究的目的是评估诊断为SJS、TEN或SJS/TEN重叠的儿科患者的临床特征,并研究治疗方式。

材料与方法

回顾性分析2019年8月至2024年1月在安卡拉比尔肯特市医院接受SJS、TEN或SJS/TEN重叠随访的0至18岁患者。

结果

12名符合纳入标准的患者被纳入研究。其中5例为SJS,4例为SJS/TEN重叠,3例为TEN。8例患者为女性,就诊时的中位年龄为10.5(四分位间距:6 - 16)岁。10例患者有用药史。8例患者使用过抗生素,2例使用过质子泵抑制剂,2例使用过别嘌醇,2例使用过抗癫痫药物(拉莫三嗪和丙戊酸)。所有12例患者均接受了静脉注射免疫球蛋白(IVIG)和全身类固醇治疗。3例TEN患者和4例SJS/TEN重叠患者接受了环孢素治疗。2例TEN患者接受了血浆置换。最常见的长期后遗症是皮肤后遗症。

结论

SJS/TEN患者应采用多学科方法进行监测,必要时在烧伤重症监护病房进行监测。主要治疗方法是支持性护理。早期使用环孢素可能对SJS/TEN重叠和TEN患者的预后产生积极影响。

相似文献

1
Evaluation of clinical features and treatment modality of pediatric patients with Steven Johnson syndrome/toxic epidermal necrolysis: a single-center experience.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症儿科患者的临床特征及治疗方式评估:单中心经验
Turk J Med Sci. 2025 Feb 5;55(2):461-469. doi: 10.55730/1300-0144.5990. eCollection 2025.
2
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.全身性治疗史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)和 SJS/TEN 重叠综合征。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.
3
Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study.拉莫三嗪成为史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的驱动因素:一项 8 年回顾性研究。
Burns. 2024 Nov;50(8):2114-2123. doi: 10.1016/j.burns.2024.07.006. Epub 2024 Jul 20.
4
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Current Management and Innovative Therapies.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:当前治疗与创新疗法综述
Int J Dermatol. 2025 Jul;64(7):1164-1172. doi: 10.1111/ijd.17768. Epub 2025 Apr 15.
5
Improving Recruitment Through Social Media and Web-Based Advertising to Evaluate the Genetic Risk and Long-Term Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Community-Based Survey.通过社交媒体和网络广告改善招募,以评估史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的遗传风险及长期并发症:基于社区的调查
J Med Internet Res. 2025 May 7;27:e63712. doi: 10.2196/63712.
6
Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的全身免疫调节疗法:系统评价与荟萃分析
JAMA Dermatol. 2017 Jun 1;153(6):514-522. doi: 10.1001/jamadermatol.2016.5668.
7
Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis.人类白细胞抗原在抗癫痫药物诱导的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症中的作用:一项荟萃分析。
Seizure. 2022 Nov;102:36-50. doi: 10.1016/j.seizure.2022.09.011. Epub 2022 Sep 17.
8
Drug-induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Ten-year Retrospective Study of 103 Cases.药物性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:103例患者的十年回顾性研究
Clin Exp Dermatol. 2025 Jun 20. doi: 10.1093/ced/llaf278.
9
Cyclosporin for the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): a systematic review of observational studies and clinical trials focusing on single therapy, combination therapy, and comparative assessments.环孢素治疗史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN):一项关于观察性研究和临床试验的系统评价,重点关注单一疗法、联合疗法及对比评估。
Inflammopharmacology. 2025 Feb;33(2):485-503. doi: 10.1007/s10787-024-01590-0. Epub 2024 Oct 29.
10
A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children.儿童药物性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症治疗的系统评价
J Popul Ther Clin Pharmacol. 2011;18:e121-33. Epub 2011 Mar 21.

本文引用的文献

1
Case Report: A successful case of toxic epidermal necrolysis treated with plasmapheresis therapy.病例报告:血浆置换疗法成功治疗中毒性表皮坏死松解症。
F1000Res. 2022 Sep 5;11:995. doi: 10.12688/f1000research.125050.1. eCollection 2022.
2
Clinical characteristics of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A single-center study.药物性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的临床特征:一项单中心研究。
Asia Pac Allergy. 2022 Apr 21;12(2):e17. doi: 10.5415/apallergy.2022.12.e17. eCollection 2022 Apr.
3
Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.
中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征:全面综述。
Adv Wound Care (New Rochelle). 2020 Jul;9(7):426-439. doi: 10.1089/wound.2019.0977. Epub 2020 Jan 9.
4
Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution.对一家儿科三级医疗机构中药物性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症病例的回顾性研究。
Pediatr Dermatol. 2020 May;37(3):461-466. doi: 10.1111/pde.14118. Epub 2020 Feb 14.
5
British Association of Dermatologists' guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018.英国皮肤科医师协会《2018年儿童和青少年史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症管理指南》
Br J Dermatol. 2019 Jul;181(1):37-54. doi: 10.1111/bjd.17841. Epub 2019 Apr 25.
6
Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.多学科团队治疗中毒性表皮坏死松解症。文献综述与治疗结果
Burns. 2018 Jun;44(4):807-815. doi: 10.1016/j.burns.2017.10.022. Epub 2018 Apr 4.
7
Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.药物诱导的皮肤不良反应:药物基因组学在其预防中的作用。
Mol Diagn Ther. 2018 Jun;22(3):297-314. doi: 10.1007/s40291-018-0330-3.
8
Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.严重迟发性药物反应:遗传学和病毒感染的作用
Immunol Allergy Clin North Am. 2017 Nov;37(4):785-815. doi: 10.1016/j.iac.2017.07.007.
9
Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity study.质子泵抑制剂诱导的迟发型超敏反应:一项临床和体外 T 细胞反应性研究。
Allergy. 2018 Jan;73(1):221-229. doi: 10.1111/all.13235. Epub 2017 Jul 30.
10
Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.儿科患者的严重皮肤药物不良反应:一项多中心研究
J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):757-763. doi: 10.1016/j.jaip.2017.02.013. Epub 2017 Mar 27.